Molecular aspects of drug development: using methods of computer modeling to create new anti-ischemic agents
Abstract
The spectra of biological activity of several derivatives of malonic acid were analyzed using computer modeling techniques with the aim to identify potentially active compounds against ischemic myocardial injury. The nature of interaction between the most promising compound based on the obtained results (4-[(3-ethoxy-3-oxopropanoyl) amino] benzoic acid) and A3 adenosine receptor was evaluated using molecular docking. Thus this compound can be regarded as a perspective anti-ischemic agent.
About the Authors
E. L. Avenirova
ГБОУ ВПО Санкт-Петербургская химико-фармацевтическая академия, Санкт-Петербург
Russian Federation
Russian Federation
P. A. Alekseeva
ГБОУ ВПО Санкт-Петербургская химико-фармацевтическая академия, Санкт-Петербург
Russian Federation
Russian Federation
N. I. Baranova
ГБОУ ВПО Санкт-Петербургская химико-фармацевтическая академия, Санкт-Петербург
Russian Federation
Russian Federation
M. S. Bass
ГБОУ ВПО Санкт-Петербургская химико-фармацевтическая академия, Санкт-Петербург
Russian Federation
Russian Federation
A. V. Buryakina
ГБОУ ВПО Санкт-Петербургская химико-фармацевтическая академия, Санкт-Петербург
Russian Federation
Russian Federation
N. N. Pitukhina
ГБОУ ВПО Санкт-Петербургская химико-фармацевтическая академия, Санкт-Петербург
Russian Federation
Russian Federation
E. V. Fedorova
ГБОУ ВПО Санкт-Петербургская химико-фармацевтическая академия, Санкт-Петербург
Russian Federation
Russian Federation
References
1. Ищенко Р.О., Федорова Е.В., Яковлев И.П. Фармация. 2013 (5). С. 41-43.
2. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S. Kar- plus M. CHARMM - a program for macromolecular energy, minimization anddynamics calculations // J. Comp. Chem. 1983. № 4. P. 187-188.
3. Gao Z.G., Kim S.K., et al. Structural determinants of A3 adenosine receptor activation-nucleoside ligands at the agonist/antagonist boundary. 2002J. Med. Chem. 45. Р. 4471-4484.
4. Gao, Z.G., et al. Identification by site-directed mutagenesis of residuesinvolved in ligand recognition and activation of the human A3 adenosine receptor. 2002J. Biol. Chem. 277. Р. 19056-19063.
5. Lagunin A., Stepanchikova A., Filimonov D., Poroikov V. Bioinformatics. 2000. 16 (8). 747 р.
6. Li Z., Wan H., Shi Y., Ouyang P. Personal experience with four kinds of chemical structure drawing software: reviewonChemDraw. ChemWindow. ISIS / Draw. and ChemSketch // J. Chem. Inf. Comput. Sci. 2004. Vol. 44. № 5. P. 1886-1890.
7. Sadym A., Lagunin A., Filimonov D., Poroikov V. SAR & QSAR Environ. Res. 2003. 14 (5-6) 339.
Review
For citations:
Avenirova E.L., Alekseeva P.A., Baranova N.I., Bass M.S., Buryakina A.V., Pitukhina N.N., Fedorova E.V. Molecular aspects of drug development: using methods of computer modeling to create new anti-ischemic agents. Journal Biomed. 2014;1(1):4-10. (In Russ.)
Views:
222
Email this article 
